WUXI BIOLOGICS (CAYMAN) INC. revenue breakdown overview

WUXI BIOLOGICS (CAYMAN) INC. revenue for the last year amounted to 2.17 B EUR, the most of which — 1.94 B EUR — came from its highest performing source at the moment, Biologics, the year earlier bringing 308.88 M EUR. The greatest contribution to the revenue figure was made by North America — last year it brought WUXI BIOLOGICS (CAYMAN) INC. 1.03 B EUR, and the year before that — 1.18 B EUR.